Nov 19, 2020
AstraZeneca and Oxford University: Confirms immune response in elderly, phase 3 vaccine trial results in weeks
AstraZeneca and Oxford University jointly developed COVID-19 vaccine-induced immune response in older adults in their phase 2 trial, the British drug
Devamını oku
Next